NO20025402L - Modifiserte ES-celler og ES-cellespesifikke gener - Google Patents
Modifiserte ES-celler og ES-cellespesifikke generInfo
- Publication number
- NO20025402L NO20025402L NO20025402A NO20025402A NO20025402L NO 20025402 L NO20025402 L NO 20025402L NO 20025402 A NO20025402 A NO 20025402A NO 20025402 A NO20025402 A NO 20025402A NO 20025402 L NO20025402 L NO 20025402L
- Authority
- NO
- Norway
- Prior art keywords
- cells
- modified
- cell specific
- specific genes
- pluripotent
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 241000271566 Aves Species 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biodiversity & Conservation Biology (AREA)
- Animal Husbandry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0006029A FR2808803B1 (fr) | 2000-05-11 | 2000-05-11 | Cellules es modifiees et gene specifique de cellules es |
PCT/FR2001/001207 WO2001085938A1 (fr) | 2000-05-11 | 2001-04-19 | Cellules es modifiees et gene specifique de cellules es |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20025402D0 NO20025402D0 (no) | 2002-11-11 |
NO20025402L true NO20025402L (no) | 2003-01-08 |
NO331814B1 NO331814B1 (no) | 2012-04-10 |
Family
ID=8850125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20025402A NO331814B1 (no) | 2000-05-11 | 2002-11-11 | Renset eller isolert nukleinsyre, isolert polypeptid, klonings- og/eller ekspresjonsvektor omfattende nukleinsyren, vertscelle, differensiert ES-celle, dyr omfattende cellene, anvendelse av nukleinsyren for pavisning og/eller amplifisering av nukleinsyresekvenser, som sens- eller antisensoligonukleotid, og fremstilling av rekombinant polypeptid, monoklonalt eller polyklonalt antistoff som selektivt binder polypeptidet, fremgangsmate for pavisning av polypeptidet, analysesett til bruk i fremgangsmaten, fremgangsmate for pavisning av pluripotent natur for ES-fuglecelle, fremgangsmate for klassifisering av fugl, DNA-chip, proteinchip, fremgangsmate for pavisning av polypeptidet i matprove, fremgangsmate for analyse av om forbindelse eller medium kan indusere differensiering av pluripotent celle, eller gjenopprette pluripotent natur, og anvendelse av nukleinsyren som promoter for gen for uttrykking av genet i pluripotent fuglecelle. |
Country Status (14)
Country | Link |
---|---|
US (2) | US20040072169A1 (no) |
EP (1) | EP1280898B1 (no) |
JP (1) | JP2004515212A (no) |
AT (1) | ATE498011T1 (no) |
AU (2) | AU5488501A (no) |
BR (1) | BR0110764A (no) |
CA (1) | CA2408732A1 (no) |
DE (1) | DE60144015D1 (no) |
DK (1) | DK1280898T3 (no) |
ES (1) | ES2358731T3 (no) |
FR (1) | FR2808803B1 (no) |
NO (1) | NO331814B1 (no) |
NZ (1) | NZ522547A (no) |
WO (1) | WO2001085938A1 (no) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2808803B1 (fr) * | 2000-05-11 | 2004-12-10 | Agronomique Inst Nat Rech | Cellules es modifiees et gene specifique de cellules es |
AU2002306374B2 (en) * | 2001-05-31 | 2008-01-24 | Dainippon Sumitomo Pharma Co., Ltd. | Genes with ES cell-specific expression |
NZ567817A (en) | 2005-11-01 | 2012-01-12 | Novartis Vaccines & Diagnostic | Cell-derived viral vaccines with low levels of residual cell DNA by beta-propiolactone treatment |
WO2007052061A2 (en) | 2005-11-04 | 2007-05-10 | Novartis Vaccines And Diagnostics Srl | Emulsions with free aqueous-phase surfactant as adjuvants for split influenza vaccines |
US20090304742A1 (en) | 2005-11-04 | 2009-12-10 | Novartis Vaccines And Diagnostics Srl | Influenza vaccines with reduced amount of emulsion adjuvant |
CN102727885A (zh) | 2005-11-04 | 2012-10-17 | 诺华疫苗和诊断有限公司 | 包含颗粒佐剂和免疫增强剂组合的流感疫苗 |
DK2368572T3 (da) | 2005-11-04 | 2020-05-25 | Seqirus Uk Ltd | Adjuvansvacciner med ikke-virionantigener fremstillet fra influenza-virusser dyrket i cellekultur |
JP2009514839A (ja) | 2005-11-04 | 2009-04-09 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル | サイトカイン誘導剤を含むアジュバントインフルエンザワクチン |
WO2007085969A2 (en) | 2006-01-27 | 2007-08-02 | Novartis Vaccines And Diagnostics Gmbh & Co Kg | Influenza vaccines containing hemagglutinin and matrix proteins |
JP2009534303A (ja) | 2006-03-24 | 2009-09-24 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス ゲーエムベーハー アンド カンパニー カーゲー | 冷蔵しないインフルエンザワクチンの保存 |
FR2898909A1 (fr) | 2006-03-24 | 2007-09-28 | Agronomique Inst Nat Rech | Combinaison de marqueurs de cellules aviaires |
GB0614460D0 (en) | 2006-07-20 | 2006-08-30 | Novartis Ag | Vaccines |
NZ577405A (en) | 2006-12-06 | 2012-08-31 | Novartis Ag | Vaccines including antigen from four strains of influenza virus |
CA2692200A1 (en) | 2007-06-27 | 2008-12-31 | Novartis Ag | Low-additive influenza vaccines |
GB0810305D0 (en) | 2008-06-05 | 2008-07-09 | Novartis Ag | Influenza vaccination |
EP2889042A3 (en) | 2008-03-18 | 2015-10-14 | Novartis AG | Improvements in preparation of influenza virus vaccine antigens |
WO2010079081A1 (en) | 2009-01-07 | 2010-07-15 | Glaxosmithkline Biologicals S.A. | Methods for recovering a virus or a viral antigen produced by cell culture |
EP2393922A1 (en) | 2009-02-06 | 2011-12-14 | GlaxoSmithKline Biologicals S.A. | Purification of virus or viral antigens by density gradient ultracentrifugation |
PL2396032T3 (pl) | 2009-02-10 | 2017-05-31 | Seqirus UK Limited | Szczepionki przeciw grypie o obniżonych zawartościach skwalenu |
EP2942062A1 (en) | 2009-02-10 | 2015-11-11 | Novartis AG | Influenza vaccine regimens for pandemic-associated strains |
US20120093860A1 (en) | 2009-02-10 | 2012-04-19 | Novartis Ag | Influenza vaccines with increased amounts of h3 antigen |
USH2284H1 (en) | 2009-04-27 | 2013-09-03 | Novartis Ag | Vaccines for protecting against influenza |
SG178904A1 (en) | 2009-09-10 | 2012-04-27 | Novartis Ag | Combination vaccines against respiratory tract diseases |
US20120309056A1 (en) | 2010-02-04 | 2012-12-06 | Leon Arnaud | Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells |
EP2545172B2 (en) | 2010-03-08 | 2017-12-06 | Novartis AG | Methods of testing for intracellular pathogens |
ES2562818T3 (es) | 2010-05-03 | 2016-03-08 | Glaxosmithkline Biologicals S.A. | Procedimiento de inactivación del virus de la gripe |
JP6072677B2 (ja) | 2010-05-06 | 2017-02-01 | ノバルティス アーゲー | 微生物の不活化のための有機ペルオキシド化合物 |
CN103025350A (zh) | 2010-05-21 | 2013-04-03 | 诺华有限公司 | 流感病毒的重配方法 |
PL2575873T3 (pl) | 2010-06-01 | 2016-06-30 | Novartis Ag | Zatężanie i liofilizacja antygenów szczepionkowych grypy |
CA2801149A1 (en) | 2010-06-01 | 2011-12-08 | Novartis Ag | Concentration of vaccine antigens without lyophilization |
CA2808965C (en) | 2010-08-20 | 2020-01-07 | Novartis Ag | Soluble needle arrays for delivery of influenza vaccines |
WO2013000982A1 (en) | 2011-06-27 | 2013-01-03 | Vivalis | Method for screening cells |
GB201216121D0 (en) | 2012-09-10 | 2012-10-24 | Novartis Ag | Sample quantification by disc centrifugation |
CA2852857A1 (en) | 2011-10-20 | 2013-04-25 | Novartis Ag | Adjuvanted influenza b virus vaccines for pediatric priming |
GB201218195D0 (en) | 2012-10-10 | 2012-11-21 | Istituto Zooprofilattico Sperimentale Delle Venezie | Composition |
ES2778928T3 (es) | 2013-08-30 | 2020-08-12 | Glaxosmithkline Biologicals Sa | Producción a gran escala de virus en cultivos celulares |
BE1023903B1 (fr) | 2014-12-16 | 2017-09-08 | Glaxosmithkline Biologicals Sa | Nouveau procédé |
JP6956635B2 (ja) | 2014-12-17 | 2021-11-02 | フンダシオン パラ ラ インベスティガシオン メディカ アプリカダ | ウィルソン病及び他の状態の処置に使用するための核酸構築物及び遺伝子治療ベクター |
KR102526616B1 (ko) | 2014-12-17 | 2023-04-27 | 푼다시온 파라 라 인베스티가시온 메디카 아플리카다 | 윌슨병 및 기타 병태의 치료에 사용되기 위한 핵산 구조물 및 유전자 치료용 벡터 |
JP2018524323A (ja) | 2015-06-26 | 2018-08-30 | セキラス ユーケー リミテッド | 抗原がマッチしたインフルエンザワクチン |
US10416171B2 (en) | 2015-07-07 | 2019-09-17 | Seqirus UK Limited | Influenza potency assays |
WO2019219649A1 (en) | 2018-05-14 | 2019-11-21 | Vivet Therapeutics | Gene therapy vectors comprising s/mar sequences |
KR20210086638A (ko) | 2018-10-12 | 2021-07-08 | 비베트 테라퓨틱스 | 진행성 가족성 간내 담즙정체 3형 (pfic3)의 치료를 위한 코돈-최적화 전이유전자 |
TW202039854A (zh) | 2018-11-16 | 2020-11-01 | 美商編碼製藥公司 | 治療威爾遜氏病的組合物和方法 |
AU2020299718A1 (en) | 2019-07-02 | 2022-02-24 | Fundacion Para La Investigacion Medica Aplicada | cPLA2e inducing agents and uses thereof |
MX2022006005A (es) | 2019-11-18 | 2022-10-27 | Seqirus Pty Ltd | Metodo para producir virus de la influenza reagrupados. |
EP4192961A2 (en) | 2020-08-06 | 2023-06-14 | Fundacion para la Investigacion Medica Aplicada | Viral particles for use in treating tauopathies such as alzheimer's diseases by gene therapy |
US20230265456A1 (en) | 2020-08-10 | 2023-08-24 | Fundacion Para La Investigacion Medica Aplicada | Gene therapy vector expressing cyp27a1 for the treatment of cerebrotendinous xanthomatosis |
EP4225782A1 (en) | 2020-10-09 | 2023-08-16 | UCB Biopharma SRL | Nucleic acid constructs, viral vectors and viral particles |
CA3234666A1 (en) | 2021-10-28 | 2023-05-04 | UCB Biopharma SRL | Nucleic acid constructs, viral vectors and viral particles |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6309822B1 (en) * | 1989-06-07 | 2001-10-30 | Affymetrix, Inc. | Method for comparing copy number of nucleic acid sequences |
FR2726003B1 (fr) * | 1994-10-21 | 2002-10-18 | Agronomique Inst Nat Rech | Milieu de culture de cellules embryonnaires totipotentes aviaires, procede de culture de ces cellules, et cellules embryonnaires totipotentes aviaires |
WO2000012683A2 (en) * | 1998-08-31 | 2000-03-09 | New York University | Stem cells bearing an fgf receptor on the cell surface |
FR2808803B1 (fr) * | 2000-05-11 | 2004-12-10 | Agronomique Inst Nat Rech | Cellules es modifiees et gene specifique de cellules es |
-
2000
- 2000-05-11 FR FR0006029A patent/FR2808803B1/fr not_active Expired - Fee Related
-
2001
- 2001-04-19 AU AU5488501A patent/AU5488501A/xx active Pending
- 2001-04-19 NZ NZ522547A patent/NZ522547A/en not_active IP Right Cessation
- 2001-04-19 BR BR0110764-0A patent/BR0110764A/pt not_active Application Discontinuation
- 2001-04-19 JP JP2001582527A patent/JP2004515212A/ja active Pending
- 2001-04-19 CA CA002408732A patent/CA2408732A1/fr not_active Abandoned
- 2001-04-19 WO PCT/FR2001/001207 patent/WO2001085938A1/fr active Application Filing
- 2001-04-19 ES ES01928006T patent/ES2358731T3/es not_active Expired - Lifetime
- 2001-04-19 AU AU2001254885A patent/AU2001254885B2/en not_active Ceased
- 2001-04-19 US US10/275,906 patent/US20040072169A1/en not_active Abandoned
- 2001-04-19 AT AT01928006T patent/ATE498011T1/de not_active IP Right Cessation
- 2001-04-19 EP EP01928006A patent/EP1280898B1/fr not_active Expired - Lifetime
- 2001-04-19 DK DK01928006.4T patent/DK1280898T3/da active
- 2001-04-19 DE DE60144015T patent/DE60144015D1/de not_active Expired - Lifetime
-
2002
- 2002-11-11 NO NO20025402A patent/NO331814B1/no not_active IP Right Cessation
-
2007
- 2007-11-21 US US11/984,835 patent/US20090151013A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2004515212A (ja) | 2004-05-27 |
FR2808803B1 (fr) | 2004-12-10 |
NO20025402D0 (no) | 2002-11-11 |
FR2808803A1 (fr) | 2001-11-16 |
ATE498011T1 (de) | 2011-02-15 |
AU5488501A (en) | 2001-11-20 |
US20040072169A1 (en) | 2004-04-15 |
US20090151013A1 (en) | 2009-06-11 |
WO2001085938A1 (fr) | 2001-11-15 |
EP1280898B1 (fr) | 2011-02-09 |
NO331814B1 (no) | 2012-04-10 |
BR0110764A (pt) | 2003-05-06 |
AU2001254885B2 (en) | 2006-08-10 |
DE60144015D1 (de) | 2011-03-24 |
ES2358731T3 (es) | 2011-05-13 |
NZ522547A (en) | 2006-02-24 |
CA2408732A1 (fr) | 2001-11-15 |
EP1280898A1 (fr) | 2003-02-05 |
DK1280898T3 (da) | 2011-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20025402L (no) | Modifiserte ES-celler og ES-cellespesifikke gener | |
Gall | The molecular biology of ciliated protozoa | |
WO2019210268A3 (en) | Sequencing-based proteomics | |
WO2003093469A3 (en) | Methods for delivering nucleic acid molecules into cells and assessment thereof | |
ES2155702T3 (es) | Construcciones expresivas halteroformes para la terapia genetica. | |
WO2003076932A3 (de) | Detektion und analyse von protein-interaktionen in vivo | |
ATE549395T1 (de) | Medium und kultur von embryonalen stammzellen | |
PL1824977T3 (pl) | Promotorowy kwas nukleinowy pochodzący z rodzaju Corynebacterium, kaseta ekspresyjna zawierająca promotor i wektor, komórka gospodarza zawierająca wektor i sposób ekspresji genu z użyciem komórki | |
DE60020855D1 (de) | Bedingte immortalisierung von zellen | |
ATE514783T1 (de) | Plasmidsystem zur expression mehrerer gene | |
EP1474507A4 (en) | METHODS AND MATERIALS FOR PRODUCING ORGANIC PRODUCTS IN CANDIDA SPECIES CELLS | |
DK1017803T3 (da) | Ekspression af endogene gener ved ikke-homolog rekombination af et vektorkonstrukt med cellulært DNA | |
DE60322880D1 (de) | Einfache katalytische dna-biosensoren für ionen auf grundlage von farbveränderungen | |
NZ597727A (en) | Cell culture medium for adamts protein expression | |
NZ538852A (en) | Selection and isolation of living cells using mRNA-binding probes | |
ATE331802T1 (de) | Sequenz-spezifische dna-rekombination in eukaryotischen zellen | |
WO2005056761A3 (en) | REAGENTS AND METHODS FOR IDENTIFICATION OF RNAi PATHWAY GENES AND CHEMICAL MODULATORS OF RNAi | |
WO2000077233A3 (en) | Complement-resistant non-mammalian dna viruses and uses thereof | |
EP1841871A4 (en) | NEW L-LYSINE INDUCIBLE PROMOTER | |
DE69928395D1 (de) | Cyclin-e2 proteine und dafür kodierende gene | |
EP1444362A4 (en) | HIGH-THROUGHPUT TRANSCRIPTOMES AND FUNCTIONAL VALIDATION ANALYSIS | |
ATE308615T1 (de) | T-bet zusammensetzungen und deren vervendungsmethoden | |
WO2005007803A3 (en) | Selection free growth of host cells containing multiple integrating vectors | |
DE69715672D1 (de) | Reporter-zellinie zum nachweis des cytomegalovirus und zur identifizierung von modulatoren der viralen genexpression | |
EP1224861A4 (en) | LARGE QUANTITIES OF A HUMAN GENE EXPRESSIVE ANIMAL AND TEST PROCEDURE THAT USE THIS ANIMAL |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |